Tendyne™ TMVI

QUALITY TIME
SECURED

.

Breakthrough therapy that can eliminate mitral regurgitation in select patients

Tendyne™ Transcatheter mitral valve implantation (TMVI) is a breakthrough technology that offers select patients who have symptomatic, significant mitral regurgitation (≥ grade 3), a new option for safe and effective valve replacement. Tendyne TMVI is less invasive than conventional mitral valve surgery and provides symptom relief and quality of life improvement by eliminating MR.

  • Complete MR elimination in 99% of patients at 30 days1
  • Sustained MR elimination in 93% of patients at 2 years1
  • 96% technical success rate in minimally invasive procedure1,*
  • Excellent safety profile1
  • Distinct product design enabling repositioning and full retrievability intraprocedurally
  • Significant improvement in symptom and quality-of-life measures1
     

*Technical success per MVARC.



Tendyne™ Transcatheter
Mitral Valve Implantation

 

MAT-2000613 v4.0 | Item approved for Global OUS use only.

References
  1.  Muller, D. Two-Year Outcomes of Tendyne Transcatheter Mitral Valve Implantation to Treat Symptomatic, Severe Mitral Regurgitation. David Muller. Presented at: PCR E-Course, June, 2020.

This site uses cookies to improve your experience.

To find out more please read our Privacy and Cookies policy.

Ok

Sign up

Receive updates from Abbott Structural Heart

YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

YOU ARE ABOUT TO LEAVE
www.structural­heart­solutions.com

You are now leaving www.structuralheartsolutions.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.